NEW YORK, Jan. 21 (GenomeWeb News) - US BioDefense is developing an open source stem cell research platform designed to enable researchers to use bioinformatics tools in order to read, distribute, modify, and contribute to research.
"We intend to quickly scale up revenues by focusing on selling open source collaborative technology research and transfer tools as well as commercializing leading edge technology," said US BioDefense CEO David Chin. He added that this will help the company tap into